Vermeer 1996.

Methods	RCT Study aim clearly defined: yes Blinded assessor of primary outcome: not stated Double blind study:yes Participants comparable at baseline for age: yes Sex: yes Duration of complaint: yes Inclusion and exclusion criteria specified: yes Interventions well described: yes Assessment of compliance: not stated Intention to treat analysis: not stated A Priori sample size calculation: not stated Fungi identified: yes Distribution of species between groups: no Adverse events reported: no Number of drop outs stated: no
Participants	Total evaluable sample size: 191 Treatment setting: Department of Dermatology (hospital)
Interventions	a. Terbinafine cream Duration: one week plus one week Placebo Frequency: b. Miconazole cream Duration: four weeks Frequency:
Outcomes	Primary outcome: cure Secondary Outcomes: Signs and symptoms ‐ itching, erythema, scaling, vesiculation
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Unclear risk	B ‐ Unclear